A voice for
herbal medicine

We share traditional, scientific and practical insights written by experienced herbalists and health experts from the world of herbal medicine and natural health

← Back to Insights

Research seeds: Meadowsweet

  • Rebecca Lazarou
    Rebecca Lazarou

    I completed my degree in Biomedical Science-Human Biology, always with the intention to study herbal medicines after. I wanted to bridge the gap between plant medicines and science. I then went on to study a masters at UCL School of Pharmacy, in Medicinal Natural Products and Phytochemistry where I learnt deeply about phytomedicines, quality control, laboratory techniques and medicinal plant science.
    Since then I have been an associate editor for the science publication Journal of Herbal Medicine. I research medicinal plants at Kew Gardens, and have been a G7 youth ambassador for healthcare. You can read more about my research here. I have launched my own botanical medicine company Laz The Plant Scientist offering herbal medicines, education and experiential events.

    I am passionate about herbal medicines as I believe medicines should prioritise prevention as well as having a holistic focus. I love that herbal medicines work to rebalance us and optimise our quality of life, and I have witnessed them having a transformative effect time and time again. I also believe that living in symbiosis with and nurturing a relationship with nature is one of the most healing things we can do.

  • 1:54 reading time (ish)
  • Research Seeds
meadowsweet

In this article, we discuss the ā€œ In vitro and in vivo assessment of meadowsweet (Filipendula ulmaria) as anti-inflammatory agentā€

Plant name and species

Ā Meadowsweet (Filipendula ulmaria (L) Maxim)

Aim of study

Meadowsweet has been traditionally used across many European countries to treat inflammatory diseases as it has antipyretic, antirheumatic, astringent and analgesic properties. This study investigates the activity of the aerial parts and roots.

Study method

The active compounds in the extract were investigated using a high-performance thin layer chromatography (HPTLC) machine. The anti-inflammatory activity was tested on cells using a method which tested cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes and COX-2 gene expression. COX-1 and COX-2 are vital for the inflammatory process as they convert arachidonic acid into prostaglandins, and prostaglandins largely control inflammation.

Herbal preparation

Methanolic extracts of both the root and aerial parts of meadowsweet were investigated.

Sample size

The plant extracts were tested on cells so there was no human sample size.

Results of study

The extracts showed that the molecules rutoside, spiraeoside and isoquercitrin were present. The extract which had the aerial parts of the plant was able to block the COX-1 enzyme activities by 62.85% and COX-2 by 46.43%. The root extract wasnā€™t as effective, but it still blocked COX-1 and COX-2 enzymes by 32.11% and 20.20% respectively.

Discussion

The COX-1 and COX-2 enzymes are heavily involved in the inflammatory processes of the gut for example with acid reflux, arthritis and acid dyspepsia. COX inhibitors are currently prescribed in pharmaceutical form as anti-inflammatory medicines, used to treat pain and a variety of conditions.Ā This study shows some of the mechanisms of action of how meadowsweet works for its traditional uses. For example meadowsweet is used to treat acid reflux (including hiatal hernia and GORD) as well as arthritis, and acid reflux, gastritis and gastric ulcers.

Conclusion

This study shows that meadowsweet has potent anti-inflammatory actions in vitro, and further investigation on people should be conducted.

Rebecca Lazarou

I completed my degree in Biomedical Science-Human Biology, always with the intention to study herbal medicines after. I wanted to bridge the gap between plant medicines and science. I then went on to... Read more

Sign up to our Newsletter

Sign up to our newsletter to receive the very latest in herbal insights.

Sign up to our newsletter